Despite the scientific and technological advances, there is currently no curative treatment for RP, with only a small group with confirmed RPE65 mutations being eligible to receive the approved gene therapy (voretigene neparvovec). The gene discussed is RPE65; the disease is retinitis pigmentosa 1.